Dr. Justin David Braverman, MD

Dr. Braverman practices at Pih Cardiovascular Testing Center / Cardiology Wells - HOPD in Whittier, California.

Dr. Braverman's NPI, 1376699504, was assigned on January 29, 2007. Dr. Braverman graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000. Dr. Braverman holds California license A96004.

Dr. Braverman's primary practice is Pih Cardiovascular Testing Center / Cardiology Wells - HOPD, at 12462 Putnam St, Whittier, CA 90602.

Dr. Braverman's primary practice is Pih Cardiovascular Testing Center / Cardiology Wells - HOPD in Whittier, California. Dr. Braverman is also affiliated with PIH Health Whittier Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Braverman to 1 more group practice or clinic, named with a free account. Dr. Braverman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Braverman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Braverman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Braverman is licensed in California.

Dmand AI lists bariatric surgery, esophagus, stomach, or upper small intestine surgery and upper GI endoscopy among the conditions Dr. Braverman treats.

CMS data shows 17 Medicare services from Dr. Braverman across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $1,563 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Braverman in 2024. The largest group is under 65, with 14 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Braverman's median patient age at 51, with 78% women.

In 2024, Dr. Braverman wrote 124 Medicare Part D claims for 43 patients. 99% of them were for generic drugs. CMS names the drug for 95 of them, across 3 drugs with 11 or more claims each, at $8,401 in total drug cost. In 2023, CMS named 119 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Braverman for performance year 2024, reported as part of a group. Dr. Braverman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 15 general payments to Dr. Braverman from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Covidien LP paid the most, $445.

Dmand AI lists 4 awards for Dr. Braverman, most recently Director of Laparoscopic and Endoscopic Surgery in 2016.

Dr. Braverman graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000. Dr. Braverman is a member of ACS, AMA and ASBP.

Dr. Braverman is in network with 8 carriers, including Aetna, Humana and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.